Purdue
The Rise of the Opioids: How Purdue Invented New Markets for OxyContin
Purdue's strategy was to market its opioids directly to patients via brochures, videos, advertisements, and the internet. It also provided information to doctors and...
Purdue Circumvented the Regulator to Promote OxyContin, Hiding Its Real Risk of Addiction
In 2001, the Food and Drug Administration required Purdue to change OxyContin’s patient package inserts to make addiction risks more evident. The company altered...
OxyContin's Academic Marketing: The Studies That Fueled the Opioid Crisis
Purdue Pharmaceuticals used to cite three major studies to argue that in prescribing OxyContin, addiction-risk was not significant. The most influential of those studies...
